Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers.

Rivka R ColenChristian RolfoMurat AkMira AyoubSara AhmedNabil ElshafeeyPriyadarshini MamindlaPascal O ZinnChaan NgRaghu VikramSpyridon BakasChristine B PetersonJordi Rodon AhnertVivek SubbiahDaniel D KarpBettzy StephenJoud HajjarAung Naing

Published in: Journal for immunotherapy of cancer (2021)

Our radiomics-based signature identified imaging differences that predicted pembrolizumab response in patients with advanced rare cancer.

Keyphrases

lymph node metastasis
papillary thyroid
advanced non small cell lung cancer
squamous cell carcinoma
childhood cancer
photodynamic therapy
epidermal growth factor receptor